Myristic Acid

Myristic Acid

SCHEMBL2124139

CC(=O)c1ccccc1.CCCCCCCCCCCCCC(=O)O

nearest known ligand 0.62

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 2/20 0.62
CES1 P23141 2/20 0.62
GPR84 Q9NQS5 7/20 0.61
PPARG P37231 7/20 0.61
PPARD Q03181 7/20 0.61
PPARA Q07869 7/20 0.61
HDAC11 Q96DB2 6/20 0.61
TSHR P16473 4/20 0.61
PTPN1 P18031 3/20 0.61
ALDH1A1 P00352 2/20 0.61
TLR2 O60603 2/20 0.61
TDP1 Q9NUW8 2/20 0.61
FABP4 P15090 2/20 0.61
KMT2A Q03164 2/20 0.61
HSD17B10 Q99714 2/20 0.61
SLC22A6 Q4U2R8 1/20 0.61
SLC22A8 Q8TCC7 1/20 0.61
MEN1 O00255 1/20 0.61
ESR1 P03372 1/20 0.61
ALOX15 P16050 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Stearic Acid SCHEMBL27740225 1.00 CES2 (0.62) CES2CES1GPR84PPARGPPARD
Acetophenone SCHEMBL28080182 0.98 CES2 (0.61) CES2CES1GPR84PPARGPPARD
Acetophenone SCHEMBL15206675 0.91 CES2 (0.61) CES2CES1ALDH1A1TDP1MAPT
Acetophenone SCHEMBL9808838 0.89 CES2 (0.62) CES2CES1TDP1KMT2AMEN1
Methyl Nonyl Ketone SCHEMBL20856835 0.89 CES2 (0.62) CES2CES1TDP1KMT2AMEN1
Acetophenone SCHEMBL28186100 0.89 CES2 (0.60) CES2CES1ALDH1A1MAPT
Acetophenone SCHEMBL28203889 0.88 L3MBTL1 (0.69) CES2CES1HDAC11TDP1HDAC3
Decanoic Acid SCHEMBL10943211 0.87 CES2 (0.64) CES2CES1GPR84PPARGPPARD
Stearic Acid SCHEMBL6765166 0.87 CES2 (0.64) CES2CES1GPR84PPARGPPARD
Heptanoate SCHEMBL5788520 0.87 CES2 (0.64) CES2CES1GPR84PPARGPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 94 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024214823-A1 LIQUID COMPOSITION, DISCHARGE PRODUCT, AND AEROSOL PRODUCT 株式会社ダイゾー 2024-10-17 WO disclosed
CN-117597411-A Foamable aerosol composition, foamable aerosol product, and method for suppressing combustibility 株式会社大造 2024-02-23 CN disclosed
US-20230416579-A1 AEROSOL RAW MATERIAL COMPOSITION, AEROSOL COMPOSITION, AND AEROSOL PRODUCT AGC Inc. (JP) 2023-12-28 US disclosed
CN-117015368-A Spray out product 株式会社大造 2023-11-07 CN disclosed
CN-117015586-A Aerosol raw material composition, aerosol composition and aerosol product AGC株式会社 2023-11-07 CN disclosed
US-11802258-B2 Perfume precursor TAKASAGO INTERNATIONAL CORPORATION (JP) 2023-10-31 US disclosed
EP-3712226-B1 CRACKING AEROSOL COMPOSITION TOYO AEROSOL IND CO (JP) 2023-05-24 EP disclosed
CN-116057161-A Composition, aerosol composition containing composition, cleaning agent, solvent, silicone solvent, foaming agent, heat transfer medium, fire extinguishing agent, and fumigant, heat transfer device containing heat transfer medium, and system containing heat transfer device 中央硝子株式会社 2023-05-02 CN disclosed
CN-111315842-B Cracking aerosol composition 东洋喷雾工业株式会社 2023-02-28 CN disclosed
WO-2023008378-A1 EFFERVESCENT AEROSOL COMPOSITION, EFFERVESCENT AEROSOL PRODUCT, COMBUSTION SUPPRESSING METHOD 株式会社ダイゾー 2023-02-02 WO disclosed
EP-1386669-A1 AEROSOL PRODUCT Daizo Corporation (JP) 2004-02-04 EP disclosed
US-20030124062-A1 Intermittently sprayed aerosol product for skin DAZIO CORPORATION (JP) 2003-07-03 US disclosed
US-6581807-B1 Aerosol product DAIZO CORPORATION (JP) 2003-06-24 US disclosed
EP-1291301-A1 AEROSOL PRODUCT Daizo Corporation (JP) 2003-03-12 EP disclosed
EP-1195173-A1 INTERMITTENTLY SPRAYED AEROSOL PRODUCT FOR SKIN Daizo Corporation (JP) 2002-04-10 EP disclosed
EP-1078868-A1 AEROSOL INJECTION DEVICE Earth Chemical Co., Ltd. (JP) 2001-02-28 EP disclosed
US-6183765-B1 SILICONE ELASTOMERS CAPABLE OF RELEASING PYRETHROID INSECTICIDES COMPRISED IN THEM, WITH OR WITHOUT HEATING, WITHOUT CHANGING THEIR FORM IN THE PROCESS. BAYER AKTIENGESELLSCHAFT (DE) 2001-02-06 US disclosed
US-6171608-B1 TRANSFLUTHRIN, EMULSIFIER, AND CO-SURFACTANTS; SUSTAINED RELEASE BAYER AKTIENGESELLSCHAFT (DE) 2001-01-09 US disclosed
US-5645845-A CONTAINING PYRETHROID-TYPE COMPOUND BAYER AKTIENGESELLSCHAFT (DE) 1997-07-08 US disclosed
US-4663315-A Device and method for vaporizing thermally vaporizable composition EARTH CHEMICAL COMPANY, LIMITED (JP) 1987-05-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11802258-B2 Perfume precursor CYP2E1, ADH1A, CYP1A1 CES2 138/4885CES1 165/4885GPR84 742/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.